Holen Sie sich die Stockscreener-App
4.56
2.93%
0.13
Handel nachbörslich:
4.44
-0.12
-2.63%
Schlusskurs vom Vortag:
$4.43
Offen:
$4.42
24-Stunden-Volumen:
31,953
Relative Volume:
0.02
Marktkapitalisierung:
$24.52M
Einnahmen:
$15.66M
Nettoeinkommen (Verlust:
$5.83M
KGV:
-0.1908
EPS:
-23.8939
Netto-Cashflow:
$466.20K
1W Leistung:
-3.80%
1M Leistung:
-26.92%
6M Leistung:
-32.74%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.3107
$4.56
1-Wochen-Bereich:
$4.13
$4.80
52-Wochen-Spanne:
$2.90
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Firmenname
Neuphoria Therapeutics Inc
Sektor
Branche
Telefon
781-439-5551
Adresse
100 SUMMIT DR, BURLINGTON
Vergleichen Sie NEUP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
4.56 | 23.82M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Neuphoria Therapeutics Sends Letter to Stockholders - MarketScreener
Neuphoria Therapeutics (NEUP) Outlines Strategic Review Ahead of Annual Meeting - GuruFocus
Making the Most of Varied Backgrounds: Ogunbufunmi’s Bold Move Toward Technology Leadership - Bitget
Neuphoria urges stockholders to vote for its nominees amid strategic review - Investing.com Canada
Neuphoria Therapeutics Inc. Sends Letter to Stockholders - Yahoo Finance
Why Did NEUP Stock Surge 64% Today? - MSN
Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital - MSN
What drives Neuphoria Therapeutics Inc stock priceStop Loss Placement Tips & Small Budget Growth - earlytimes.in
Tenax Therapeutics, Inc. (TENX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How supply chain issues affect Neuphoria Therapeutics Inc. stock2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Will Neuphoria Therapeutics Inc. stock continue upward momentumMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
What does recent volatility data suggest for Neuphoria Therapeutics Inc.2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
What indicators show strength in Neuphoria Therapeutics Inc.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
How to read the order book for Neuphoria Therapeutics Inc.Weekly Trend Summary & Target Return Focused Picks - newser.com
Is Neuphoria Therapeutics Inc. still worth holding after the dipQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com
Is Neuphoria Therapeutics Inc. meeting your algorithmic filter criteriaTrend Reversal & Reliable Trade Execution Plans - newser.com
What Wall Street predicts for Neuphoria Therapeutics Inc. stock price2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com
Can Neuphoria Therapeutics Inc. stock maintain operating marginsTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
Is Neuphoria Therapeutics Inc. stock attractive after correctionJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Neuphoria Therapeutics may offer & sell common stock of up to $20 million from time to timeSEC filing - MarketScreener
Can Neuphoria Therapeutics Inc. stock hit analyst price targetsAnalyst Downgrade & Real-Time Price Movement Reports - Fundação Cultural do Pará
Will Neuphoria Therapeutics Inc. stock deliver shareholder value2025 Analyst Calls & Accurate Entry and Exit Point Alerts - Fundação Cultural do Pará
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - MSN
Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView
Neuphoria Therapeutics Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025 - MarketScreener
Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):